NCT00122538View on ClinicalTrials.gov

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

May 31, 2009

Conditions

HIV InfectionsAIDS

Interventions

DRUG

Efavirenz (EFV)

DRUG

Lamivudine (3TC)

DRUG

Didanosine (ddI)

Trial Locations (1)

01 BP 676

Service de pediatrie, CHU Sanou Souro, Bobo-Dioulasso

All Listed Sponsors

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00122538 - Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) | Biotech Hunter | Biotech Hunter